Black Rock Inc. Puma Biotechnology, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,572,806 shares of PBYI stock, worth $9.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,572,806

Previous 1,617,558 120.88%

Holding current value

$9.22 Million

Previous $8.57 Million 35.86%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.92 - $5.83 $5.71 Million - $11.4 Million	1,955,248 Added 120.88%	3,572,806 $11.6 Million
Q1 2024 May 10, 2024	BUY	$4.29 - $7.4 $313,281 - $540,392	73,026 Added 4.73%	1,617,558 $8.57 Million
Q4 2023 Feb 13, 2024	BUY	$2.23 - $4.49 $153,470 - $309,006	68,821 Added 4.66%	1,544,532 $6.69 Million
Q3 2023 Nov 13, 2023	SELL	$2.63 - $4.09 $109,392 - $170,119	-41,594 Reduced 2.74%	1,475,711 $3.88 Million
Q2 2023 Aug 11, 2023	SELL	$2.6 - $3.58 $4,256 - $5,860	-1,637 Reduced 0.11%	1,517,305 $5.36 Million
Q1 2023 May 12, 2023	SELL	$2.21 - $4.82 $32,261 - $70,362	-14,598 Reduced 0.95%	1,518,942 $4.69 Million
Q4 2022 Feb 13, 2023	SELL	$2.12 - $5.08 $696,689 - $1.67 Million	-328,627 Reduced 17.65%	1,533,540 $6.49 Million
Q3 2022 Nov 14, 2022	SELL	$2.27 - $3.84 $93,001 - $157,324	-40,970 Reduced 2.15%	1,862,167 $4.41 Million
Q2 2022 Aug 12, 2022	SELL	$1.64 - $3.3 $2.42 Million - $4.87 Million	-1,476,547 Reduced 43.69%	1,903,137 $5.43 Million
Q1 2022 May 12, 2022	BUY	$2.13 - $3.24 $373,702 - $568,448	175,447 Added 5.48%	3,379,684 $9.73 Million
Q4 2021 Feb 10, 2022	SELL	$2.85 - $6.58 $9,758 - $22,529	-3,424 Reduced 0.11%	3,204,237 $9.74 Million
Q3 2021 Nov 09, 2021	BUY	$6.63 - $9.39 $940,777 - $1.33 Million	141,897 Added 4.63%	3,207,661 $22.5 Million
Q2 2021 Aug 11, 2021	BUY	$8.98 - $11.6 $27.5 Million - $35.6 Million	3,065,764 New	3,065,764 $28.1 Million

Others Institutions Holding PBYI

# of Institutions

Shares Held

30.5M

Call Options Held

73.5K

Put Options Held

18.5K

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $118M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account